Literature DB >> 21905229

Inhibition of aminoglycoside-deactivating enzymes APH(3')-IIIa and AAC(6')-Ii by amphiphilic paromomycin O2''-ether analogues.

Janek Szychowski1, Jiro Kondo, Omar Zahr, Karine Auclair, Eric Westhof, Stephen Hanessian, Jeffrey W Keillor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21905229      PMCID： PMC5179253          DOI： 10.1002/cmdc.201100346

Source DB:  PubMed          Journal:  ChemMedChem        ISSN： 1860-7179            Impact factor:   3.466


× No keyword cloud information.
  50 in total

1.  Conformational switch in the decoding region of 16S rRNA during aminoacyl-tRNA selection on the ribosome.

Authors:  T Pape; W Wintermeyer; M V Rodnina
Journal:  Nat Struct Biol       Date:  2000-02

2.  Structural analyses of nucleotide binding to an aminoglycoside phosphotransferase.

Authors:  D L Burk; W C Hon; A K Leung; A M Berghuis
Journal:  Biochemistry       Date:  2001-07-31       Impact factor: 3.162

3.  Substrate promiscuity of an aminoglycoside antibiotic resistance enzyme via target mimicry.

Authors:  Desiree H Fong; Albert M Berghuis
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

4.  Overexpression and characterization of the chromosomal aminoglycoside 6'-N-acetyltransferase from Enterococcus faecium.

Authors:  G D Wright; P Ladak
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

5.  RNA sequence determinants for aminoglycoside binding to an A-site rRNA model oligonucleotide.

Authors:  M I Recht; D Fourmy; S C Blanchard; K D Dahlquist; J D Puglisi
Journal:  J Mol Biol       Date:  1996-10-04       Impact factor: 5.469

6.  Letter: Synthesis of (S)-4-amino-2-hydroxybutyryl derivatives of 3',4'-dideoxykanamycin B and their antibacterial activities.

Authors:  S Kondo; K Iinuma; H Yamamoto; Y Ikeda; K Maeda
Journal:  J Antibiot (Tokyo)       Date:  1973-11       Impact factor: 2.649

7.  3',4'-dideoxy-kanamycin B active against kanamycin-resistant Escherichia coli and Pseudomonas aeruginosa.

Authors:  H Umezawa; S Umezawa; T Tsuchiya; Y Okazaki
Journal:  J Antibiot (Tokyo)       Date:  1971-07       Impact factor: 2.649

8.  The Synthesis of L-aminosugar and the studies of L-pyranoses on the ring III of pyranmycins.

Authors:  Jinhua Wang; Jie Li; David Tuttle; Jon Y Takemoto; Cheng-Wei Tom Chang
Journal:  Org Lett       Date:  2002-11-14       Impact factor: 6.005

9.  Aminoglycoside dosages and nephrotoxicity: quantitative relationships.

Authors:  Florent Rougier; Michel Ducher; Michel Maurin; Stéphane Corvaisier; Daniel Claude; Roger Jelliffe; Pascal Maire
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

10.  Complete kinetic mechanism of elongation factor Tu-dependent binding of aminoacyl-tRNA to the A site of the E. coli ribosome.

Authors:  T Pape; W Wintermeyer; M V Rodnina
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598
View more
  13 in total

1.  6''-Thioether tobramycin analogues: towards selective targeting of bacterial membranes.

Authors:  Ido M Herzog; Keith D Green; Yifat Berkov-Zrihen; Mark Feldman; Roee R Vidavski; Anat Eldar-Boock; Ronit Satchi-Fainaro; Avigdor Eldar; Sylvie Garneau-Tsodikova; Micha Fridman
Journal:  Angew Chem Int Ed Engl       Date:  2012-04-12       Impact factor: 15.336

2.  A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription.

Authors:  Indrajit Das; Jérôme Désiré; Dinesh Manvar; Isabelle Baussanne; Virendra N Pandey; Jean-Luc Décout
Journal:  J Med Chem       Date:  2012-06-22       Impact factor: 7.446

3.  A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosides.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2015-11-19       Impact factor: 3.597

Review 4.  Comprehensive review of chemical strategies for the preparation of new aminoglycosides and their biological activities.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Chem Soc Rev       Date:  2018-02-19       Impact factor: 54.564

5.  Antifungal Amphiphilic Aminoglycosides.

Authors:  C-W T Chang; J Y Takemoto
Journal:  Medchemcomm       Date:  2014-08-01       Impact factor: 3.597

Review 6.  Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections.

Authors:  Kristin J Labby; Sylvie Garneau-Tsodikova
Journal:  Future Med Chem       Date:  2013-07       Impact factor: 3.808

7.  Selectively guanidinylated aminoglycosides as antibiotics.

Authors:  Richard J Fair; Mary E Hensler; Wdee Thienphrapa; Quang N Dam; Victor Nizet; Yitzhak Tor
Journal:  ChemMedChem       Date:  2012-05-25       Impact factor: 3.466

8.  Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.

Authors:  Marina Y Fosso; Sanjib K Shrestha; Keith D Green; Sylvie Garneau-Tsodikova
Journal:  J Med Chem       Date:  2015-12-01       Impact factor: 7.446

Review 9.  Prospects for circumventing aminoglycoside kinase mediated antibiotic resistance.

Authors:  Kun Shi; Shane J Caldwell; Desiree H Fong; Albert M Berghuis
Journal:  Front Cell Infect Microbiol       Date:  2013-06-25       Impact factor: 5.293

10.  Structural basis for selective targeting of leishmanial ribosomes: aminoglycoside derivatives as promising therapeutics.

Authors:  Moran Shalev; Haim Rozenberg; Boris Smolkin; Abedelmajeed Nasereddin; Dmitry Kopelyanskiy; Valery Belakhov; Thomas Schrepfer; Jochen Schacht; Charles L Jaffe; Noam Adir; Timor Baasov
Journal:  Nucleic Acids Res       Date:  2015-08-11       Impact factor: 16.971
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.